Schedule 13G ownership disclosure

N/A

Common Stock, $0.001 par value per share · CUSIP: 14179K101

Event date: 2025-04-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Perceptive Advisors LLC

    Shares: 1,170,810 · Class: 2.5%

  • Joseph Edelman

    Shares: 1,170,810 · Class: 2.5%

  • Perceptive Life Sciences Master Fund, Ltd.

    Shares: 0 · Class: 0.0%

  • Perceptive Xontogeny Venture Fund II, L.P.

    Shares: 1,170,810 · Class: 2.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-057630
Form type
SCHEDULE 13G/A
Filer
CARGO Therapeutics, Inc.
CIK
CIK 1966494
Filed
Apr 23, 2025
Reporting period
Apr 23, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub